Frontlight ResearchEarly access
Trial site
Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences
- 1running trial
The trials here
What the trial at this site is about, from its registry record.
- Conditions
Running trials
Active, not recruiting
Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC
Site data: ClinicalTrials.govUpdated 12 Nov 2026